Tuesday September 24, 2019 0 comments
With this new appointment, Oz will advise PanTheryx on strategies to expand its impact on health and wellness through its leading technology position and focus on colostrum science.
“We’re thrilled to have Dr. Mehmet Oz join us on the board of directors,” said Mark Braman, PanTheryx CEO.
“As a company, we are committed to unlocking the vast health and therapeutic benefits of bovine colostrum through robust clinical science. Dr. Oz’s insight and guidance will be pivotal in helping us to reach that goal.”
Oz brings decades of medical, nutrition, wellness, and communications expertise to the PanTheryx board. As former vice-chair and professor of surgery at Columbia University Medical Center, he is a world-renowned practicing cardiothoracic surgeon who has authored over 400 original publications, articles, and medical books.
He is also co-founder of Health Corps, a national nonprofit with a mission to educate and improve physical and mental health in American teens.
Oz received his undergraduate degree from Harvard University and obtained a joint MD and MBA from the University of Pennsylvania School of Medicine and Wharton Business School.
PanTheryx was founded in 2007 to create nutritional solutions for pediatric infectious diarrhea, the second-leading killer of children under the age of five in the developing world.
“I’m excited to be joining PanTheryx’s board at such an important time in the company’s development,” said Oz. “Research and real-world experience point to the pivotal role our gut plays in maintaining and restoring health. It is essential to overall well-being.
“Through the innovative use of colostrum, PanTheryx is pioneering the development of nutrition-based interventions and biologics to dramatically improve global health safely and effectively.”